---
layout: study_note
title: "Reproducibility, Benchmarks, and Translational Study Design"
description: "Designing studies whose results survive contact with another site and another team."
tab: "trustworthy-ai"
tab_title: "Trustworthy AI"
category: "evaluation"
category_title: "Evaluation, Generalization & Reliability"
order: 12
source: "Independent study"
written: true
updated: "2026-09-08"
---

A reproducible medical AI study makes its analysis inspectable and repeatable, while a translational study asks whether the result remains useful in clinical practice. Benchmarks help compare methods, but they cannot supply all the evidence needed for either claim.

## Core question and definition

I use computational reproducibility to mean obtaining consistent results from the same data and specified analysis. Independent replication asks whether another team or dataset supports the substantive conclusion. Terminology varies across fields, so I would state what was repeated rather than rely on the label alone.

The central question is which parts of a result depend on undocumented choices, familiar benchmark conditions, or one team's workflow. Repeating the original score and demonstrating benefit at another hospital are different achievements.

## Key concepts

### Specify the experiment beyond the architecture

A checkpoint depends on cohort construction, preprocessing, software versions, optimization, random initialization, model selection, and aggregation. Reproducing only the network diagram leaves much of the experiment unspecified. [CLAIM](https://doi.org/10.1148/ryai.2020200029) provides reporting guidance for medical imaging AI. I read transparent methods as the basis for checking a claim, rather than evidence that the claim is already correct.

### Treat a benchmark as a measurement instrument

A benchmark fixes a task, sample, reference, split, and scoring rule. This supports comparison only when participants use compatible conditions. Repeated tuning against a public test set can gradually turn it into development data. A stronger benchmark result may also reflect more pretraining data or computation rather than the proposed method, so comparison budgets and permitted data need documentation.

### Match the study design to the stage of translation

Retrospective testing examines recorded cases. Prospective silent evaluation processes incoming cases without showing outputs to clinicians and can expose timing, missing-input, and integration problems. Early live evaluation adds human interaction, the focus of [DECIDE-AI](https://doi.org/10.1038/s41591-022-01772-9). Comparative clinical studies then ask whether introducing the system changes decisions or outcomes. These stages answer complementary questions rather than forming interchangeable demonstrations of readiness.

### Evaluate the intervention that people actually use

The clinical intervention includes the model version, interface, instructions, escalation process, and users' responses. [CONSORT-AI](https://doi.org/10.1038/s41591-020-1034-x) addresses reporting of trials involving AI interventions, including human interaction and error analysis. Randomization can strengthen causal comparisons, but the unit of randomization must account for shared workflows and contamination between assisted and unassisted care.

## Worked examples in medical AI

Consider a hypothetical gallbladder classifier reproduced by a second team using the original images and checkpoint. Matching predictions would support computational reproducibility. If that team then evaluates new examinations from its own hospital, it is testing transportability under a different population and acquisition process. Disagreement at that stage does not necessarily mean the original implementation was irreproducible.

A subsequent hypothetical silent study might reveal that the required lesion crop is unavailable before reporting. The retrospective task would then be poorly matched to deployment despite reproducible accuracy. A live study would additionally need to examine whether clinicians follow, ignore, or overinterpret the output. None of these questions is settled by an improved benchmark ranking.

## Evaluation methods and limitations

I would retain versioned cohort definitions, split identifiers, preprocessing specifications, checkpoints, and executable evaluation instructions. Where patient data cannot be released, controlled access, a detailed data dictionary, and test examples can still expose important assumptions. Synthetic examples can test implementation behavior but cannot reproduce the original clinical performance distribution.

For translation, I would prespecify eligibility, comparator, outcomes, sample-size rationale, and handling of unavailable predictions. Evaluation should include the patients for whom the pipeline fails to produce an answer. Reporting checklists improve transparency; they do not replace sound design, independent evaluation, or adequate follow-up. A study also needs to identify which model updates would change the intervention being evaluated.

## Research connections and open questions

My gallbladder audits should be reproducible as procedures, including feature definitions, interventions, and statistical comparisons. I would want another team to recover the audit conclusion, not merely regenerate the same heatmaps from a supplied checkpoint.

- Which undocumented choices are most likely to change an audit's conclusion?
- What can another institution reproduce when the original ultrasound examinations cannot be shared?
- Which clinical outcome would demonstrate that an audit-informed model improves the intended workflow?

## References

- Mongan, Moy, and Kahn, [Checklist for Artificial Intelligence in Medical Imaging (CLAIM): A Guide for Authors and Reviewers](https://doi.org/10.1148/ryai.2020200029), Radiology: Artificial Intelligence 2020.
- Vasey et al., [Reporting guideline for the early-stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI](https://doi.org/10.1038/s41591-022-01772-9), Nature Medicine 2022.
- Liu et al., [Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension](https://doi.org/10.1038/s41591-020-1034-x), Nature Medicine 2020.
